| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 16/01/2024 | 07:49 | Dow Jones News | Roche's Cancer Injection Tecentriq SC Gets European Commission Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/01/2024 | 14:45 | InvestorsHub NewsWire | GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 29/12/2023 | 23:07 | Dow Jones News | LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 19/12/2023 | 16:27 | Dow Jones News | Roche's Xolair Granted FDA Priority Review | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 11/12/2023 | 16:31 | Dow Jones News | Poseida Therapeutics Shares Climb on Positive Data for Blood Cancer Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 08/12/2023 | 18:56 | Dow Jones News | Roche Obtains Positive Data on Early-Stage Breast Cancer Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 08/12/2023 | 18:38 | Dow Jones News | Roche's Inavolisib Breast Cancer Drug Gets Positive Results | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 06/12/2023 | 11:14 | Dow Jones News | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 05/12/2023 | 07:54 | Dow Jones News | Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 04/12/2023 | 16:12 | Dow Jones News | Trending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 Billion | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 04/12/2023 | 12:34 | Dow Jones News | Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- Update | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 04/12/2023 | 11:55 | IH Market News | Alaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and More | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 04/12/2023 | 07:47 | Dow Jones News | Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Billion | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 21/11/2023 | 17:06 | Dow Jones News | Roche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AI | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 07/11/2023 | 23:14 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 31/10/2023 | 07:26 | Dow Jones News | Roche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main Goal | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 27/10/2023 | 07:40 | Dow Jones News | Roche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 23/10/2023 | 21:41 | Dow Jones News | Trending: Roche to Buy Telavant From Roivant and Pfizer | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 23/10/2023 | 10:16 | Dow Jones News | Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- Update | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 23/10/2023 | 07:50 | Dow Jones News | Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion Deal | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 19/10/2023 | 11:55 | Dow Jones News | Roche Shares Fall on Lower Sales Due to Currency Hit | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 19/10/2023 | 07:48 | Dow Jones News | Roche Backs Guidance After Sales Fall | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 18/10/2023 | 08:14 | Dow Jones News | Roche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage Trial | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 18/10/2023 | 07:54 | Dow Jones News | Roche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal Sepsis | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 29/09/2023 | 14:15 | Dow Jones News | AbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short in Multiple Myeloma | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 27/09/2023 | 13:59 | Dow Jones News | Ionis, Roche Set New Pact Targeting Alzheimer's, Huntington's | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 20/09/2023 | 14:45 | InvestorsHub NewsWire | Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 06/09/2023 | 07:52 | Dow Jones News | Roche's Blood Disorder Drug Crovalimab Takes Step Toward FDA Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 01/09/2023 | 08:04 | Dow Jones News | Roche Lung Cancer Drug Shows Promise in Phase 3 Trial | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 29/08/2023 | 11:51 | Dow Jones News | Roche's Tecentriq Intravenous Cancer Therapy Gets UK Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |